Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment

Conditions

• Lower Extremity Lymphedema

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Advanced pneumatic compression device (APCD) — DEVICE
  Single APCD treatment session at visit 1
• Advanced pneumatic compression device (APCD) with revised compression programming — DEVICE
  APCD with revised compression programming will be single treatment session at visit 2
• Indocyanine Green (IC-Green) — DRUG
  Indocyanine Green dye will be used to assess primary endpoint

Study Details

The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?

Key Dates

First listed

May 29, 2026

Start date

Jul 31, 2026

Status verified

Jul 2026

Primary completion

Sep 30, 2026

Completion

Sep 30, 2026

Study Design

Enrollment

5 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

DEVICE_FEASIBILITY

Arms

• Experimental: Treatment group

Primary Outcome Measure

Lymphatic anatomy [ Time Frame: Before and after 60-minute treatment in clinic with APCD ]

Central Contacts

• Senior Vice President Marketing and Market Access
  1.833.382.2845
  [email protected]

Locations (1)

Find similar trials in Houston, TX